Showing results (21-30 of 1,066) with videos related to

Sort By:
Pageof 107
European Journal of Clinical Pharmacology|January 1, 1992
Steady-state plasma levels of clomipramine and its metabolites: impact of the sparteine/debrisoquine oxidation polymorphism. Danish University Antidepressant GroupK K Nielsen, K Brøsen, L F Gram
Clinical Pharmacology and Therapeutics|November 1, 1986
Imipramine demethylation and hydroxylation: impact of the sparteine oxidation phenotypeK Brøsen, S V Otton, L F Gram
Acta Pharmacologica Et Toxicologica|November 1, 1985
Sparteine oxidation polymorphism in DenmarkK Brøsen, S V Otton, L F Gram
European Journal of Clinical Pharmacology|April 25, 2001
Are there differences in the use of selective serotonin reuptake inhibitors and tricyclic antidepressants? A prescription database studyJ U Rosholm, M Andersen, L F Gram
British Journal of Clinical Pharmacology|June 1, 1994
Concurrent use of more than one major psychotropic drug (polypsychopharmacy) in out-patients--a prescription database studyJ U Rosholm, J Hallas, L F Gram
British Journal of Clinical Pharmacology|June 1, 1986
Sparteine oxidation polymorphism: a family studyK Brøsen, S V Otton, L F Gram
European Journal of Clinical Pharmacology|June 13, 1975
Kinetics of nortriptyline in man according to a two compartment modelK F Overo, L F Gram, V Hansen
Acta Pharmacologica Et Toxicologica|January 1, 1977
Interaction of perphenazine with the kinetics of nortriptylineK F Overo, L F Gram, V Hansen
Clinical Pharmacology and Therapeutics|March 1, 1992
Pharmacokinetics of the selective serotonin reuptake inhibitor paroxetine: nonlinearity and relation to the sparteine oxidation polymorphismS H Sindrup, K Brøsen, L F Gram
British Journal of Clinical Pharmacology|March 1, 1990
A dose-effect study of the in vivo inhibitory effect of quinidine on sparteine oxidation in manM D Nielsen, K Brøsen, L F Gram
Pageof 107